Search

Your search keyword '"Dörk, Thilo"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Dörk, Thilo" Remove constraint Author: "Dörk, Thilo" Database Journals@OVID Remove constraint Database: Journals@OVID
49 results on '"Dörk, Thilo"'

Search Results

1. Body mass index and breast cancer survival: a Mendelian randomization analysis

2. Association analysis identifies 65 new breast cancer risk loci

3. PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations

4. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

5. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

6. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

7. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

8. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

10. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

11. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

12. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

13. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

14. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

15. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

16. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

17. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

18. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

19. Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

21. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

22. CYP2B6*6 is associated with increased breast cancer risk

23. Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome

24. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

25. The role of genetic breast cancer susceptibility variants as prognostic factors

26. 11q13 Is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer

28. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†

31. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

32. A role for XRCC2 gene polymorphisms in breast cancer risk and survival

34. Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

37. Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042

38. Association of ESR1 gene tagging SNPs with breast cancer risk

39. NBS1 variant I171V and breast cancer risk

42. Genome-wide association study identifies novel breast cancer susceptibility loci

46. Dominant Negative ATM Mutations in Breast Cancer Families

47. Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study

Catalog

Books, media, physical & digital resources